$354 Million is the total value of Aequim Alternative Investments LP's 47 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 84.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | MICROCHIP TECHNOLOGY INCnote 2.250% 2/1 | $32,453,000 | +17.5% | 27,500,000 | +10.0% | 9.17% | -7.1% | |
| Buy | REALPAGE INCnote 1.500%11/1 | $30,036,000 | +55.7% | 20,000,000 | +60.0% | 8.48% | +23.1% | |
| Buy | LIBERTY MEDIA CORPdeb 3.500% 1/1 | $24,472,000 | +84.6% | 27,500,000 | +57.1% | 6.91% | +45.9% | |
| Buy | J2 GLOBAL INCnote 3.250% 6/1 | $22,340,000 | +11.3% | 16,000,000 | +6.7% | 6.31% | -12.0% | |
| Buy | INSULET CORPnote 1.250% 9/1 | $15,384,000 | +86.3% | 7,500,000 | +50.0% | 4.34% | +47.3% | |
| INTEQ | Buy | INTELSAT S A | $14,232,000 | +416.4% | 731,700 | +315.7% | 4.02% | +308.1% |
| Buy | NICE SYS INCnote 1.250% 1/1 | $11,939,000 | +30.0% | 7,000,000 | +16.7% | 3.37% | +2.8% | |
| CNPPRB | Buy | CENTERPOINT ENERGY INCdep rp pfd cv b | $10,044,000 | +35.8% | 200,000 | +42.9% | 2.84% | +7.3% |
| New | MICROCHIP TECHNOLOGY INCnote 1.625% 2/1 | $8,837,000 | – | 5,000,000 | +100.0% | 2.50% | – | |
| New | CYPRESS SEMICONDUCTOR CORPnote 4.500% 1/1 | $8,404,000 | – | 5,000,000 | +100.0% | 2.37% | – | |
| TEAM | New | ATLASSIAN CORP PLCcl a | $6,817,000 | – | 52,100 | +100.0% | 1.92% | – |
| TSLA | Buy | TESLA INC | $4,112,000 | +27.8% | 18,400 | +60.0% | 1.16% | +1.0% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $3,845,000 | +18.0% | 116,200 | +24.9% | 1.09% | -6.7% |
| New | WRIGHT MED GROUP N Vnote 2.250%11/1 | $3,709,000 | – | 2,500,000 | +100.0% | 1.05% | – | |
| CCCWS | New | CLARIVATE ANALYTICS PLC*w exp 11/09/201 | $3,563,000 | – | 750,000 | +100.0% | 1.01% | – |
| SATS | New | ECHOSTAR CORPcl a | $3,085,000 | – | 69,600 | +100.0% | 0.87% | – |
| CLF | New | CLEVELAND CLIFFS INC | $2,973,000 | – | 278,600 | +100.0% | 0.84% | – |
| EEFT | New | EURONET WORLDWIDE INC | $1,514,000 | – | 9,000 | +100.0% | 0.43% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $942,000 | – | 11,000 | +100.0% | 0.27% | – |
| ASCMA | Buy | ASCENT CAP GROUP INC | $465,000 | +105.8% | 430,984 | +43.1% | 0.13% | +61.7% |
| JCPNQ | Buy | PENNEY J C CORP INC | $456,000 | +22.3% | 400,000 | +60.0% | 0.13% | -3.0% |
| CNSL | New | CONSOLIDATED COMM HLDGS INC | $436,000 | – | 88,500 | +100.0% | 0.12% | – |
| NIO | New | NIO INCspon ads | $332,000 | – | 130,300 | +100.0% | 0.09% | – |
| RRD | Buy | DONNELLEY R R & SONS CO | $202,000 | -18.5% | 102,500 | +95.2% | 0.06% | -36.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NICE SYS INC | 19 | Q3 2023 | 6.3% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2023 | 0.8% |
| EURONET WORLDWIDE ORD | 18 | Q3 2023 | 0.4% |
| CLEVELAND CLIFFS ORD | 17 | Q3 2023 | 1.9% |
| AIR TRANSPORT SERVICES GRP I | 17 | Q1 2023 | 0.5% |
| LIBERTY MEDIA CORP DELAWARE | 16 | Q3 2023 | 5.6% |
| ECHOSTAR CORP | 16 | Q3 2023 | 0.9% |
| BAUSCH HEALTH COS INC | 15 | Q1 2023 | 0.3% |
| O-I GLASS INC | 15 | Q3 2023 | 0.2% |
| JAZZ PHARMACEUTICALS PLC | 14 | Q3 2023 | 0.1% |
View Aequim Alternative Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Aequim Alternative Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.